| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Hans-Josef Feistritzer | Q87282317 |
| P2093 | author name string | Gert Klug | |
| Bernhard Metzler | |||
| Johannes Mair | |||
| Sebastian Johannes Reinstadler | |||
| P2860 | cites work | Prognostic value of copeptin: one-year outcome in patients with traumatic brain injury | Q82789786 |
| Combination of copeptin and high-sensitivity cardiac troponin T assay in unstable angina and non-ST-segment elevation myocardial infarction: a pilot study | Q83320848 | ||
| Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease | Q83342800 | ||
| C-terminal provasopressin (copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction Peptide II (LAMP II) study | Q83394499 | ||
| Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction | Q83455763 | ||
| Copeptin is associated with mortality in patients with traumatic brain injury | Q83898407 | ||
| Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study | Q84361073 | ||
| Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia | Q84456823 | ||
| Sensitive troponin I assay in early diagnosis of acute myocardial infarction | Q84473723 | ||
| The high-sensitivity cardiac troponin T assay is superior to its previous assay generation for prediction of 90-day clinical outcome in ischemic stroke | Q84492083 | ||
| Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction | Q84637493 | ||
| Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay | Q84947952 | ||
| Copeptin is a predictive biomarker of severity in acute pancreatitis | Q85921538 | ||
| Copeptin level after carotid endarterectomy and perioperative stroke | Q86049440 | ||
| Plasma copeptin levels are associated with prognosis of severe acute pancreatitis | Q86634684 | ||
| Long-term predictive value of copeptin after acute myocardial infarction: a cardiac magnetic resonance study | Q87199504 | ||
| Copeptin is associated with the severity of endometriosis | Q87217422 | ||
| Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndro | Q87298461 | ||
| Plasma copeptin as a predictor of intoxication severity and delayed neurological sequelae in acute carbon monoxide poisoning | Q87412900 | ||
| Postoperative plasma copeptin levels independently predict delirium and cognitive dysfunction after coronary artery bypass graft surgery | Q87465716 | ||
| The 90-day prognostic value of copeptin in acute intracerebral hemorrhage | Q87814773 | ||
| A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction | Q22252541 | ||
| Synthesis, Transport, and Release of Posterior Pituitary Hormones | Q22299406 | ||
| Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction | Q28271905 | ||
| Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction | Q30442265 | ||
| Effects of aging on vasopressin production in a kindred with autosomal dominant neurohypophyseal diabetes insipidus due to the DeltaE47 neurophysin mutation | Q30672287 | ||
| Plasma and platelet vasopressin in essential hypertension and congestive heart failure | Q33481937 | ||
| A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study | Q33855133 | ||
| Circulating levels of copeptin, a novel biomarker in pre-eclampsia | Q33875627 | ||
| C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study | Q34003454 | ||
| Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects. | Q34005206 | ||
| Copeptin: clinical use of a new biomarker | Q34010057 | ||
| Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease. | Q34012825 | ||
| Incremental value of copeptin for rapid rule out of acute myocardial infarction | Q34018239 | ||
| Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). | Q34036575 | ||
| Development and Clinical Application of a New Method for the Radioimmunoassay of Arginine Vasopressin in Human Plasma | Q34052781 | ||
| Copeptin improves early diagnosis of acute myocardial infarction | Q34113939 | ||
| Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension | Q34248479 | ||
| Third universal definition of myocardial infarction | Q34295914 | ||
| Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI. | Q47397915 | ||
| Predictive value of NT-pro BNP after acute myocardial infarction: relation with acute and chronic infarct size and myocardial function | Q47587026 | ||
| The positive predictive value of ct-proAVP (copeptin) in patients with STEMI. | Q47969196 | ||
| C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction | Q47974191 | ||
| Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment | Q47994672 | ||
| Brain natriuretic peptide and copeptin levels are associated with cardiovascular disease in patients with chronic kidney disease. | Q48126857 | ||
| Highly sensitive cardiac troponin T and long-term mortality in a population of community-derived perimenopausal women: nested case-control study | Q48212804 | ||
| Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure | Q48252671 | ||
| Prevalence, characteristics and outcome of non-cardiac chest pain and elevated copeptin levels | Q48693596 | ||
| Plasma copeptin level predicts acute traumatic coagulopathy and progressive hemorrhagic injury after traumatic brain injury | Q48729688 | ||
| Association of aortic stiffness with biomarkers of myocardial wall stress after myocardial infarction | Q48879256 | ||
| Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients. | Q50648308 | ||
| Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. | Q50702996 | ||
| Prognostic significance of plasma copeptin detection compared with multiple biomarkers in intracerebral hemorrhage. | Q50707122 | ||
| Early rule out of acute myocardial infarction in ED patients: value of combined high-sensitivity cardiac troponin T and ultrasensitive copeptin assays at admission. | Q50866189 | ||
| Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men. | Q50866258 | ||
| The utility of copeptin in the emergency department for non-ST-elevation myocardial infarction rapid rule out: COPED-MIRRO study. | Q50897001 | ||
| Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. | Q50982435 | ||
| Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. | Q51377088 | ||
| Heart-type fatty acid-binding protein may exclude acute myocardial infarction on admission to emergency department for chest pain. | Q51773961 | ||
| Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. | Q52925939 | ||
| Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trial. | Q54550627 | ||
| Late microvascular obstruction after acute myocardial infarction: relation with cardiac and inflammatory markers. | Q54619838 | ||
| The utility of copeptin in the emergency department as a predictor of adverse outcomes in non-ST-elevation acute coronary syndrome: the COPED-PAO study | Q57631474 | ||
| Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD | Q57759362 | ||
| How to use high-sensitivity cardiac troponins in acute cardiac care | Q58314226 | ||
| High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis | Q60976474 | ||
| Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction | Q62128951 | ||
| Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I | Q73911973 | ||
| Evidence for a vasopressin system in the rat heart | Q74452840 | ||
| ??? | Q22242895 | ||
| Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study | Q35059506 | ||
| Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction | Q35569452 | ||
| Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia | Q36642006 | ||
| High-sensitivity cardiac troponin T levels are increased in stable COPD. | Q36677305 | ||
| Blood levels of copeptin on admission predict outcomes in out-of-hospital cardiac arrest survivors treated with therapeutic hypothermia | Q36928204 | ||
| The combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: a prospective observational study | Q36972479 | ||
| Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). | Q37193463 | ||
| Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria | Q37278044 | ||
| Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. | Q37599608 | ||
| Diagnostic accuracy of copeptin sensitivity and specificity in patients with suspected non-ST-elevation myocardial infarction with troponin I below the 99th centile at presentation | Q37684756 | ||
| Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome | Q37716537 | ||
| High-sensitivity cardiac troponins in everyday clinical practice | Q37722773 | ||
| The stress hormone copeptin: a new prognostic biomarker in acute illness | Q37792919 | ||
| Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care | Q37835560 | ||
| Biomarkers and acute coronary syndromes: an update | Q38172885 | ||
| Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study. | Q38424432 | ||
| Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study | Q38487799 | ||
| Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction | Q39414391 | ||
| Copeptin improves the diagnostic performance of sensitive troponin I-Ultra but cannot rapidly rule out non-ST-elevation myocardial infarction at presentation to an emergency department. | Q39456438 | ||
| Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses. | Q39621711 | ||
| N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte | Q40576611 | ||
| Prognostic significance of hypothalamic-pituitary-adrenal axis hormones in early sepsis: a study performed in the emergency department | Q41738647 | ||
| Copeptin: a novel, independent prognostic marker in patients with ischemic stroke | Q43207505 | ||
| Early diagnosis of myocardial infarction with sensitive cardiac troponin assays | Q43285257 | ||
| Prognostic significance of cardiovascular biomarkers and renal dysfunction in outpatients with systolic heart failure: a long term follow-up study | Q43494428 | ||
| Plasma copeptin, a possible prognostic marker in cirrhosis | Q43639386 | ||
| Copeptin for rapid rule out of acute myocardial infarction in emergency department | Q43739273 | ||
| C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction | Q43795750 | ||
| Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischaemic stroke | Q43901436 | ||
| Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy. | Q43948807 | ||
| Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections | Q44180412 | ||
| Comparison of contemporary troponin assays with the novel biomarkers, heart fatty acid binding protein and copeptin, for the early confirmation or exclusion of myocardial infarction in patients presenting to the emergency department with chest pain | Q44325501 | ||
| Plasma copeptin and long-term outcomes in acute ischemic stroke | Q44470659 | ||
| Combined copeptin and troponin to rule out myocardial infarction in patients with chest pain and a history of coronary artery disease. | Q44479215 | ||
| Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. | Q44494351 | ||
| Properties of human vasopressin precursor constructs: inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus | Q44946237 | ||
| Increased levels of copeptin before clinical diagnosis of preelcampsia | Q45002550 | ||
| Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes | Q45743912 | ||
| Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy | Q46444144 | ||
| Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. | Q46518454 | ||
| Serum levels of copeptin, C-reactive protein and cortisol in different severity groups of sickle cell anaemia | Q46580477 | ||
| Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin | Q46790418 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | carbohydrate | Q11358 |
| peptide | Q172847 | ||
| glycopeptide | Q2425020 | ||
| myocardial infarction | Q12152 | ||
| acute myocardial infarction | Q18558122 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 614145 | |
| P577 | publication date | 2015-04-16 | |
| P1433 | published in | Disease Markers | Q15756044 |
| P1476 | title | Copeptin testing in acute myocardial infarction: ready for routine use? | |
| P478 | volume | 2015 |
| Q42370383 | Circulating micro ribonucleic acids in cardiovascular disease: a look beyond myocardial injury |
| Q64986825 | Clinical role of serum Copeptin in acute coronary syndrome. |
| Q57101391 | Diagnostic accuracy of adding copeptin to cardiac troponin for non-ST-elevation myocardial infarction: A systematic review and meta-analysis |
| Q38841682 | Novel biomarkers predicting cardiac function after acute myocardial infarction |
| Q92741233 | Performance of Copeptin for Early Diagnosis of Acute Myocardial Infarction in an Emergency Department Setting |
| Q39195160 | Redefining the role of biomarkers in heart failure trials: expert consensus document |
| Q37356064 | Screening of gestational diabetes mellitus in early pregnancy by oral glucose tolerance test and glycosylated fibronectin: study protocol for an international, prospective, multicentre cohort trial |
| Q42330837 | The role of circulating microRNAs in acute coronary syndromes: ready for prime time? |
Search more.